CN114601879A - 一种丰胸乳膏及其制备方法和使用方法 - Google Patents
一种丰胸乳膏及其制备方法和使用方法 Download PDFInfo
- Publication number
- CN114601879A CN114601879A CN202210443284.6A CN202210443284A CN114601879A CN 114601879 A CN114601879 A CN 114601879A CN 202210443284 A CN202210443284 A CN 202210443284A CN 114601879 A CN114601879 A CN 114601879A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- cream
- breast
- composition
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000481 breast Anatomy 0.000 title claims abstract description 53
- 239000006071 cream Substances 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000341 volatile oil Substances 0.000 claims abstract description 84
- 239000000203 mixture Substances 0.000 claims abstract description 52
- 239000002994 raw material Substances 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 10
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 10
- 239000002562 thickening agent Substances 0.000 claims abstract description 10
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 9
- 229930003944 flavone Natural products 0.000 claims abstract description 9
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 9
- 235000011949 flavones Nutrition 0.000 claims abstract description 9
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- 241000251468 Actinopterygii Species 0.000 claims abstract description 8
- 102000008186 Collagen Human genes 0.000 claims abstract description 8
- 108010035532 Collagen Proteins 0.000 claims abstract description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 230000017531 blood circulation Effects 0.000 claims abstract description 8
- 229920001436 collagen Polymers 0.000 claims abstract description 8
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 235000010445 lecithin Nutrition 0.000 claims abstract description 8
- 239000000787 lecithin Substances 0.000 claims abstract description 8
- 229940067606 lecithin Drugs 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 7
- 238000010521 absorption reaction Methods 0.000 claims abstract description 7
- 229940109850 royal jelly Drugs 0.000 claims abstract description 7
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 6
- 244000068988 Glycine max Species 0.000 claims abstract description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 238000005728 strengthening Methods 0.000 claims abstract description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 4
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 18
- 230000003014 reinforcing effect Effects 0.000 claims description 15
- 244000178870 Lavandula angustifolia Species 0.000 claims description 13
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 13
- 239000001102 lavandula vera Substances 0.000 claims description 13
- 235000018219 lavender Nutrition 0.000 claims description 13
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 12
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 12
- 240000007551 Boswellia serrata Species 0.000 claims description 12
- 239000004863 Frankincense Substances 0.000 claims description 12
- 241000220317 Rosa Species 0.000 claims description 12
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 claims description 12
- 210000003811 finger Anatomy 0.000 claims description 11
- -1 geranium extract Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 10
- 240000002505 Pogostemon cablin Species 0.000 claims description 10
- 238000001467 acupuncture Methods 0.000 claims description 10
- 235000020221 chamomile extract Nutrition 0.000 claims description 10
- 229940119217 chamomile extract Drugs 0.000 claims description 10
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 9
- 240000005385 Jasminum sambac Species 0.000 claims description 9
- 210000000038 chest Anatomy 0.000 claims description 9
- 229940105040 geranium extract Drugs 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 240000000513 Santalum album Species 0.000 claims description 6
- 235000008632 Santalum album Nutrition 0.000 claims description 6
- 244000028419 Styrax benzoin Species 0.000 claims description 6
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 6
- 235000008411 Sumatra benzointree Nutrition 0.000 claims description 6
- 229960002130 benzoin Drugs 0.000 claims description 6
- 239000001224 daucus carota l. seed absolute Substances 0.000 claims description 6
- 235000019382 gum benzoic Nutrition 0.000 claims description 6
- 238000003825 pressing Methods 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 6
- 241000475481 Nebula Species 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 230000001976 improved effect Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 240000007436 Cananga odorata Species 0.000 claims description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 3
- 244000183685 Citrus aurantium Species 0.000 claims description 3
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 241000675108 Citrus tangerina Species 0.000 claims description 3
- 244000301850 Cupressus sempervirens Species 0.000 claims description 3
- 240000006927 Foeniculum vulgare Species 0.000 claims description 3
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 3
- 240000003553 Leptospermum scoparium Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 244000179970 Monarda didyma Species 0.000 claims description 3
- 235000010672 Monarda didyma Nutrition 0.000 claims description 3
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 3
- 235000002911 Salvia sclarea Nutrition 0.000 claims description 3
- 244000182022 Salvia sclarea Species 0.000 claims description 3
- 206010053615 Thermal burn Diseases 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 230000006978 adaptation Effects 0.000 claims description 3
- 230000003416 augmentation Effects 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000005057 refrigeration Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 210000003813 thumb Anatomy 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 5
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004556 brain Anatomy 0.000 abstract description 7
- 230000003340 mental effect Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000008451 emotion Effects 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 abstract 1
- 210000002445 nipple Anatomy 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000003796 beauty Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010043268 Tension Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 244000209700 shan ge teng Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006179 Breast atrophy Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000008738 Clausena lansium Nutrition 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种丰胸乳膏及其制备方法和使用方法,属于丰胸乳膏领域,由以下百分比质量原料组成:加强组合物30‑35%、辅助组合物20‑25%、维生素C6‑8%、王不留行4‑6%、野葛根4‑6%、大豆異黃酮4‑6%、蜂皇浆4‑6%、卵磷脂3‑5%、乳化剂8‑10%、当归2‑3%、鱼皮胶原蛋白6‑8%和增稠剂8‑10%。通过加入精油成分和按摩手法,用以辅助精神放松的辅助组合物,香气会进入脑中的脑叶系统,透过精油的嗅吸,大脑会产生愉快的感觉,帮助情绪释放,有助于舒缓全身的压力,在人体和精神放松的情况下,身体会更好的吸收有利于自身的药物成分和加强体内反应,乳膏能够加速擦涂部位的血液循环,增加新陈代谢别实现活血化瘀的效果,让使用者从内到外的产生反应,更好的发挥效果。
Description
技术领域
本发明涉及丰胸乳膏技术领域,尤其涉及一种丰胸乳膏及其制备方法和使用方法。
背景技术
拥有哺乳功能、性感功能和特有的女性美象征为一体的美丽乳房,是每个女性梦寐以求的。在讲求“健康就是美”的现代社会里,女性乳房“美”的功能已渐渐成为美女标准的必要条件之一。每一个女性都希望有一对丰满而富有弹性的乳房。
经检索,公告号CN201710765082.2的中国专利,公开了一种丰胸美胸组合物、乳膏及制备方法、使用方法,其实现了修复乳房萎缩、外扩、下垂、扁平、起皱及发育不良造成的贫乳的美胸增大护理;能促进乳房二次发育,通过热敷、按摩、负压激活乳腺细胞,促进乳房血液循环并快速聚集脂肪,促使乳腺发育,使乳房饱满、圆润、紧致、结实。
CN105997640A公开了一种含植物成分的丰胸护肤品,包括以下组分:葡萄多酚、腊肠树果黄酮、啤酒花黄酮、益母草黄酮、葛根黄酮、水解胶原蛋白、油脂、乳化剂、增稠剂、保湿剂、防腐剂和芳香剂,余量为去离子水,该产品采用缺少对乳房组织发育不良、早衰松弛的科学认知,而盲目添加多种丰胸成分,导致丰胸健胸效果不佳,稳定性差。
主要解决的问题是在丰胸的同时如何为乳房提供更好的保护。
但是,进行丰胸产品的使用者,首先考虑的更多是达到丰胸效果,往往针对乳房的保护还会选择其它针对性的产品,而在采用丰胸乳膏进行丰胸的过程中,乳膏的药效的发挥和使用者本身息息相关,身体的不吸收、情绪的滴落、血液不循环、使用过于潦草均会影响最终的效果,现有的乳膏产生无法更多的提供相应的配合效果。
发明内容
本发明的目的是为了解决现有技术中存在的缺陷,而提出的丰胸乳膏及其制备方法和使用方法。
为了实现上述目的,本发明采用了如下技术方案:
根据本发明的一个目的,提供了一种丰胸乳膏。
一种丰胸乳膏,由以下百分比质量原料组成:
加强组合物30-35%、辅助组合物20-25%、维生素C6-8%、王不留行4-6%、野葛根4-6%、大豆異黃酮4-6%、蜂皇浆4-6%、卵磷脂3-5%、乳化剂8-10%、当归2-3%、鱼皮胶原蛋白6-8%和增稠剂8-10%。
进一步地,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、安息香精油、檀香精油和苦橙叶精油。
进一步地,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、依兰精油和快乐鼠尾草精油。
进一步地,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、柠檬精油、红柑提取液、丝柏提取液、茶树精油、佛手柑提取液和迷迭香精油。
进一步地,所述辅助组合物由以下原料等比研磨混合制备:沉香,安息香、乳香、白芷和小茴香。
本发明的另一个目的在于用于上述丰胸乳膏的制备方法,因此本发明在上述技术方案的基础上,同时提出如下技术方案:
一种丰胸乳膏的制备方法,包括以下步骤:
步骤一:按比例称取上述原料并准备蒸馏水备用;
步骤二:分别取出加强组合物和辅助组合物,并将剩余材料以4:4:2分为三份;
步骤三:将加强组合物和辅助组合物各取出20%与最小份的剩余材料通过反应釜混合搅拌;
步骤四:将剩余的加强组合物和辅助组合物分别与剩余的两份材料通过反应釜在70-95℃下混合搅拌;
步骤五:将步骤四中获得的两份材料存储至容器中;
步骤六:将步骤三中获得的材料,铺覆在容器中,并放置进入冰箱中冷藏10-20分钟;
步骤七:取出、密封,完成制备。
进一步地,用于步骤五中,存储至容器中的方式为两份材料左右对称均匀分布。
进一步地,用于步骤五中,存储至容器中的方式为两份材料依次间隔分布,每层的厚度相同。
根据本发明的另一个目的,还包括了一种丰胸乳膏的使用方法。
一种丰胸乳膏的使用方法,包括以下步骤:
步骤一:用温度45-60℃的热水缓慢持续冲洗擦涂部位10-15分钟,使用者感受微热、微烫即可;
步骤二:将乳膏和75℃以上的纯净水以1:6的比例进行稀释,并均匀涂抹到胸部,其中,擦涂过程中,感觉擦涂润滑没有摩擦感即可;
步骤三:采用灸疗设备将蒸汽引导至人体正面,并以擦涂部位为中心,向四周引导,温度递进下降,根据人体适应的不同,最高不得超过65℃;
需要说明的是,灸疗设备选用采用蒸汽的艾灸仪器,也可替换为具有相同功能的仪器。
步骤四:在蒸汽熏蒸擦涂部位的同时,将需要数量的涂抹的乳膏一通进行熏蒸加热,并在熏蒸至少5分钟后,将药膏取出在手心;
步骤五:将乳膏在手心摩擦,待手心感到发热后,开始擦涂胸部;
步骤六:通过按摩手法,在乳膏涂覆完全的同时对胸部进行按摩,住进血液循环加快吸收;
步骤七:在按摩至少十分钟后,将热毛巾敷在胸部,并对底部进行支撑,持续10分钟,完成使用。
进一步地,在步骤五中,按摩手法的具体步骤为:寻找膻中、乳根、磨窗、屋翳、库房、神封等穴位;
找到穴位之后,以拇指指腹压住穴位,并慢慢加大力度下压,下压完成的时间不少五5秒不高于8秒,同时指力要已深入穴位,感到疼痛即可;
下压到底后,停留2-3秒,并在5秒内渐渐全部松开,间隔2-3秒后,重复指压的动作;
每个穴位反复操作5次后移动到下一穴位,从当前穴位换到下一穴位时,保持下压力度,直线滑动至下一穴位处。
相比于现有技术,本发明的有益效果在于:通过加入精油成分和按摩手法,可以让皮肤更好的吸收乳膏的药效,进入血管与全身的组织中,此外,用以辅助精神放松的辅助组合物,其香气对的情绪能够产生莫大影响,香气会进入脑中的脑叶系统,透过精油的嗅吸,大脑会产生愉快的感觉,帮助情绪释放,有助于舒缓全身的压力,在人体和精神放松的情况下,身体会更好的吸收有利于自身的药物成分和加强体内反应,从而大大增加如皋效果;
同时,乳膏的制备还能够通过不同组分的搭配实现针对不同皮肤的针对性改变,保留药效的同时,降低对皮肤的损伤,而在促进吸收的同时,乳膏能够加速擦涂部位的血液循环,增加新陈代谢别实现活血化瘀的效果,起到有效治疗的同时,还能够在使用过程中,给使用者提供放松和保健护理的效果,让效果不局限擦涂效果,而是让使用者从内到外的产生反应,更好的发挥效果。
附图说明
附图用来提供对本发明的进一步理解,并且构成说明书的一部分,与本发明的实施例一起用于解释本发明,并不构成对本发明的限制。
图1为本发明提出的丰胸乳膏的制备方法的步骤流程图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。
为了更好的理解本发明的技术方案,以下对各原料进行阐述:
维生素C:又称维他命C,是一种多羟基化合物,保持血管的完整,促进非血红素铁吸收等所必需,同时维生素C还具备有抗氧化,抗自由基,抑制酪氨酸酶的形成,从而达到美白,淡斑的功效;
王不留行:季果实成熟、果皮尚未开裂时采割植株,晒干,打下种子,除去杂质,再晒干,具有活血通经,下乳消肿,利尿通淋的功效。用于经闭,痛经,乳汁不下,乳痈肿痛,淋证涩痛
大豆异黄酮:是大豆生长中形成的一类次级代谢产物,是一种生物活性物质,由于是从植物中提取,对于雌激素水平低者,大豆异黄酮表现为弱雌激素作用,与成骨细胞内的雌激素受体结合,加强成骨细胞的活性,促进骨基质的产生、分泌和骨矿化过程,可预防骨质疏松症的发生。
蜂皇浆:工蜂舌腺分泌的物质,有光泽感,具有抗辐射,抑制和杀死癌细胞的作用,能调节内分泌,养颜美容,延缓衰老,防止机体老化;
卵磷脂,又称为蛋黄素,存在于动植物组织及卵黄中的一组黄褐色的油脂性物质。可使大脑神经及时得到营养补充,保持健康的工作状态,利于消除疲劳,激化脑细胞,改善因神经紧张而引起的急躁、易怒、失眠等症;
乳化剂:能使两种或两种以上互不相溶的组分的混合液体形成稳定的乳状液的一类物质;
增稠剂:又称胶凝剂,是一种能增加胶乳、液体黏度的物质,用于食品时又称糊料。增稠剂可以提高物系黏度,使物系保持均匀稳定的悬浮状态或乳浊状态,或形成凝胶;大多数增稠剂兼具乳化作用。可分为天然和合成两大类,天然品大多数从含多糖类黏性物质的植物和海藻类制取,如淀粉、阿拉伯胶、果胶、琼脂、明胶、海藻胶、角叉胶、糊精等,通用明胶、可溶性淀粉、多糖衍生物等可用于化妆品;合成品有羧甲基纤维素、丙二醇藻蛋白酸酯、甲基纤维素、淀粉磷酸钠、羧甲基纤维素钠、藻蛋白酸钠、酪蛋白、聚丙烯酸钠、聚氧乙烯、聚乙烯吡咯烷酮等;
鱼皮胶原蛋白:是鱼皮结缔组织中的主要成分,也是鱼类体内含量最多、分布最广的功能性蛋白,具有良好的生物相容性、可生物降解性以及生物活性,因此在食品、医药、组织工程、化妆品等领域获得广泛的应用
玫瑰精油:玫瑰精油是世界上最昂贵的精油,被称为“精油之后”。能调整女性内分泌,滋养子宫,缓解痛经,改善性冷淡和更年期不适。尤其是具有很好的美容护肤作用,能以内养外淡化斑点,促进黑色素分解,改善皮肤干燥,恢复皮肤弹性,让女性拥有白皙、充满弹性的健康肌肤,是适宜女性保健的芳香精油,玫瑰花味辛、甘,性微温,有理气解郁之效。
檀香精油:檀香精油适合老化、干燥及缺水皮肤,可淡化疤痕、细纹、滋润肌肤、预防皱纹;具镇静特质,能安抚神经紧张和焦虑,使人放松;具催情特性,高效补肾,松弛神经,改善性冷淡檀香可行气温心;
广藿香精油:功效:郁症、镇静、催情、滋补、收敛、利尿、消炎、抗菌、促进伤口愈合,除臭、解虫及蛇咬伤的毒。最大特色在聚合作用,伤口既促进伤口结疤,预防发炎,促进细胞新陈代谢;
洋甘菊提取液:蒸馏自花朵,安抚效果绝佳,可舒解焦虑、紧张、愤怒与恐惧,使人放松有耐性,感觉祥和。减轻忧虑,让心灵平静,对失眠很有帮;
薰衣草精油:薰衣草精油是由薰衣草提炼而成,可以清热解毒,清洁皮肤,控制油分,祛斑美白,祛皱嫩肤、祛除眼袋黑眼圈,还可促进受损组织再生恢复等护肤功能。薰衣草精油还对心脏有镇静效果,可降低高血压、安抚心悸,对于失眠很有帮助。
根据本发明的实施例,提供了一种丰胸乳膏。
实施例一
一种丰胸乳膏,由以下百分比质量原料组成:
加强组合物30%、辅助组合物20%、维生素C6%、王不留行4%、野葛根4%、大豆異黃酮4%、蜂皇浆4%、卵磷脂3%、乳化剂8%、当归2%、鱼皮胶原蛋白6%和增稠剂8%。
实施例二
一种丰胸乳膏,由以下百分比质量原料组成:
加强组合物32.5%、辅助组合物22.5%、维生素C7%、王不留行5%、野葛根5%、大豆異黃酮5%、蜂皇浆5%、卵磷脂4%、乳化剂9%、当归2.5%、鱼皮胶原蛋白7%和增稠剂9%。
实施例三
一种丰胸乳膏,由以下百分比质量原料组成:
加强组合物35%、辅助组合物25%、维生素C8%、王不留行6%、野葛根6%、大豆異黃酮6%、蜂皇浆6%、卵磷脂5%、乳化剂8-10%、当归3%、鱼皮胶原蛋白8%和增稠剂10%。
在相同发明的优选实施例中,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、安息香精油、檀香精油和苦橙叶精油;
需要说明的是,该实施方式用于对针对干性皮肤使用者的使用。
在相同发明的另一优选实施例中,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、依兰精油和快乐鼠尾草精油。
需要说明的是,该实施方式用于对针对一般皮肤使用者的使用。
在相同发明的另一优选实施例中,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、柠檬精油、红柑提取液、丝柏提取液、茶树精油、佛手柑提取液和迷迭香精油;
需要说明的是,该实施方式用于对针对油性皮肤使用者的使用。
其中,所述辅助组合物由以下原料等比研磨混合制备:沉香、安息香、乳香、白芷、小茴香。
根据本发明的另一个实施例,提供了一种丰胸乳膏的制备方法。
如图1所示,一种丰胸乳膏的制备方法,包括以下步骤:
步骤S101:按比例称取上述原料并准备蒸馏水备用;
步骤S103:分别取出加强组合物和辅助组合物,并将剩余材料以4:4:2分为三份;
步骤S105:将加强组合物和辅助组合物各取出20%与最小份的剩余材料通过反应釜混合搅拌;
步骤S107:将剩余的加强组合物和辅助组合物分别与剩余的两份材料通过反应釜在70-95℃下混合搅拌;
步骤S109:将步骤S107中获得的两份材料存储至容器中;
步骤S111:将步骤S105中获得的材料,铺覆在容器中,并放置进入冰箱中冷藏10-20分钟;
步骤S113:取出、密封,完成制备。
在一个优选实施例中,用于步骤五中,存储至容器中的方式为两份材料左右对称均匀分布。
在一个优选实施例中,用于步骤五中,存储至容器中的方式为两份材料依次间隔分布,每层的厚度相同。
根据本发明的另一个实施目的,提供了一种丰胸乳膏的使用方法。
一种丰胸乳膏的使用方法,包括以下步骤:
步骤S201:用温度45-60℃的热水缓慢持续冲洗擦涂部位10-15分钟,使用者感受微热、微烫即可;
步骤S203:将乳膏和75℃以上的纯净水以1:6的比例进行稀释,并均匀涂抹到胸部(涂抹厚度为擦涂过程中,感觉擦涂比较润滑不摩擦);
步骤S205:采用灸疗设备将蒸汽引导至人体正面,并以擦涂部位为中心,向四周引导,温度递进下降,根据人体适应的不同,最高不得超过65℃;
步骤S207:在蒸汽熏蒸擦涂部位的同时,将需要数量的涂抹的乳膏一通进行熏蒸加热,并在熏蒸至少5分钟后,将药膏取出在手心;
步骤S209:将乳膏在手心摩擦,待手心感到发热后,开始擦涂胸部;
步骤S211:通过按摩手法,在乳膏涂覆完全的同时对胸部进行按摩,住进血液循环加快吸收;
步骤S213:在按摩至少十分钟后,将热毛巾敷在胸部,并对底部进行支撑,持续10分钟,完成使用。
在本申请的具体实施例中,在步骤S209中,按摩手法的具体步骤为:寻找膻中、乳根、磨窗、屋翳、库房、神封等穴位;
找到穴位之后,以拇指指腹压住穴位,并慢慢加大力度下压,下压完成的时间不少五5秒不高于8秒,同时指力要已深入穴位,感到疼痛即可;
下压到底后,停留2-3秒,并在5秒内渐渐全部松开,间隔2-3秒后,重复指压的动作;
每个穴位反复操作5次后移动到下一穴位,从当前穴位换到下一穴位时,保持下压力度,直线滑动至下一穴位处。
需要进行说明的是,在上述步骤中:各个穴位的位置为:
膻中(属任脉):两乳头连线中点;
乳根(属足阳明胃经):乳头正下方,乳房下缘处;
磨窗(属足阳明胃经):乳头正上方两横指处,第3肋间隙;
屋翳(属足阳明胃经):乳头正上方,第2肋间隙;
库房(属足阳明胃经):乳头正上方约四横指处;
神封(属足少阴肾经):乳头水平,前正中线旁开2寸。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (10)
1.一种丰胸乳膏,其特征在于,由以下百分比质量原料组成:
加强组合物30-35%、辅助组合物20-25%、维生素C6-8%、王不留行4-6%、野葛根4-6%、大豆異黃酮4-6%、蜂皇浆4-6%、卵磷脂3-5%、乳化剂8-10%、当归2-3%、鱼皮胶原蛋白6-8%和增稠剂8-10%。
2.根据权利要求1所述的丰胸乳膏,其特征在于,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、安息香精油、檀香精油和苦橙叶精油。
3.根据权利要求1所述的丰胸乳膏,其特征在于,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、胡萝卜籽油、依兰精油和快乐鼠尾草精油。
4.根据权利要求1所述的丰胸乳膏,其特征在于,所述加强组合物由以下原料等比搅拌混合制备:
洋甘菊提取液、广藿香精油、天竺葵提取液、薰衣草精油、玫瑰精油、橙花提取液、茉莉精油、乳香精油、柠檬精油、红柑提取液、丝柏提取液、茶树精油、佛手柑提取液和迷迭香精油。
5.根据权利要求1所述的丰胸乳膏,其特征在于,所述辅助组合物由以下原料等比研磨混合制备:沉香,安息香、乳香、白芷和小茴香。
6.一种丰胸乳膏的制备方法,用于权利要求1-5任一所述的丰胸乳膏的制备方法,其特征在于,包括以下步骤:
步骤一:按比例称取上述原料并准备蒸馏水备用;
步骤二:分别取出加强组合物和辅助组合物,并将剩余材料以4:4:2分为三份;
步骤三:将加强组合物和辅助组合物各取出20%与最小份的剩余材料通过反应釜混合搅拌;
步骤四:将剩余的加强组合物和辅助组合物分别与剩余的两份材料通过反应釜在70-95℃下混合搅拌;
步骤五:将步骤四中获得的两份材料存储至容器中;
步骤六:将步骤三中获得的材料,铺覆在容器中,并放置进入冰箱中冷藏10-20分钟;
步骤七:取出、密封,完成制备。
7.根据权利要求6所述的丰胸乳膏的制备方法,其特征在于,用于步骤五中,存储至容器中的方式为两份材料左右对称均匀分布。
8.根据权利要求6所述的丰胸乳膏的制备方法,其特征在于,用于步骤五中,存储至容器中的方式为两份材料依次间隔分布,每层的厚度相同。
9.根据权利要求1-5任一所述的丰胸乳膏,其特征在于,丰胸乳膏的使用方法,包括以下步骤:
步骤一:用温度45-60℃的热水缓慢持续冲洗擦涂部位10-15分钟,使用者感受微热、微烫即可;
步骤二:将乳膏和75℃以上的纯净水以1:6的比例进行稀释,并均匀涂抹到胸部,其中,擦涂过程中,感觉擦涂润滑没有摩擦感即可;
步骤三:采用灸疗设备将蒸汽引导至人体正面,并以擦涂部位为中心,向四周引导,温度递进下降,根据人体适应的不同,最高不得超过65℃;
步骤四:在蒸汽熏蒸擦涂部位的同时,将需要数量的涂抹的乳膏一通进行熏蒸加热,并在熏蒸至少5分钟后,将药膏取出在手心;
步骤五:将乳膏在手心摩擦,待手心感到发热后,开始擦涂胸部;
步骤六:通过按摩手法,在乳膏涂覆完全的同时对胸部进行按摩,住进血液循环加快吸收;
步骤七:在按摩至少十分钟后,将热毛巾敷在胸部,并对底部进行支撑,持续10分钟,完成使用。
10.根据权利要求9中所述的丰胸乳膏,其特征在于,在步骤五中,按摩手法的具体步骤为:寻找膻中、乳根、磨窗、屋翳、库房、神封等穴位;
找到穴位之后,以拇指指腹压住穴位,并慢慢加大力度下压,下压完成的时间不少五5秒不高于8秒,同时指力要已深入穴位,感到疼痛即可;
下压到底后,停留2-3秒,并在5秒内渐渐全部松开,间隔2-3秒后,重复指压的动作;
每个穴位反复操作5次后移动到下一穴位,从当前穴位换到下一穴位时,保持下压力度,直线滑动至下一穴位处。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210443284.6A CN114601879A (zh) | 2022-04-25 | 2022-04-25 | 一种丰胸乳膏及其制备方法和使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210443284.6A CN114601879A (zh) | 2022-04-25 | 2022-04-25 | 一种丰胸乳膏及其制备方法和使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114601879A true CN114601879A (zh) | 2022-06-10 |
Family
ID=81869479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210443284.6A Pending CN114601879A (zh) | 2022-04-25 | 2022-04-25 | 一种丰胸乳膏及其制备方法和使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114601879A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420448A (zh) * | 2016-09-25 | 2017-02-22 | 安徽旺润生物科技有限公司 | 一种丰胸健乳膏 |
CN108096389A (zh) * | 2017-11-24 | 2018-06-01 | 广州绿人生物科技有限公司 | 一种美胸组合物及其制备方法和应用 |
CN108785163A (zh) * | 2018-07-03 | 2018-11-13 | 郑州博凯医药保健品有限公司 | 丰胸乳膏及其制备方法和使用方法 |
CN110368457A (zh) * | 2019-08-23 | 2019-10-25 | 嵇莓芳 | 一种纯天然芳香植物精油的丰胸健胸产品配方及制备方法 |
-
2022
- 2022-04-25 CN CN202210443284.6A patent/CN114601879A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420448A (zh) * | 2016-09-25 | 2017-02-22 | 安徽旺润生物科技有限公司 | 一种丰胸健乳膏 |
CN108096389A (zh) * | 2017-11-24 | 2018-06-01 | 广州绿人生物科技有限公司 | 一种美胸组合物及其制备方法和应用 |
CN108785163A (zh) * | 2018-07-03 | 2018-11-13 | 郑州博凯医药保健品有限公司 | 丰胸乳膏及其制备方法和使用方法 |
CN110368457A (zh) * | 2019-08-23 | 2019-10-25 | 嵇莓芳 | 一种纯天然芳香植物精油的丰胸健胸产品配方及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104814890B (zh) | 一种沉香型护发、生发精油及其制备方法 | |
CN102552096A (zh) | 一种乌发生发洗发液及其制备方法 | |
CN108653006A (zh) | 一种植物保湿全效眼霜及其制备方法 | |
CN107157909A (zh) | 一种防脱发洗发水 | |
CN102846503A (zh) | 一种清凉去屑滋养保健型洗头膏及其制备方法 | |
CN105796457B (zh) | 一种富含天然提取物的祛疤祛痘印乳液及其制备方法 | |
CN108158885A (zh) | 修复妊娠纹的组合物及其制备方法和应用 | |
CN105132219A (zh) | 一种淡化萎缩纹的香皂及其制备方法 | |
CN107157835A (zh) | 一种预防或修复妊娠纹的复方精油及其制备方法 | |
CN111617197A (zh) | 一种生发养发的中药组合物及其制备方法与应用 | |
CN106727269A (zh) | 纯天然纳米植物酵素面膜 | |
CN109199932A (zh) | 一种能减少脱发的复方精油 | |
CN109223299A (zh) | 一种蒸汽热敷理疗产品及其制备方法 | |
CN105213279A (zh) | 一种消除萎缩纹的身体乳及其制备方法 | |
CN106398919A (zh) | 一种抗氧化手工皂 | |
CN106994148A (zh) | 一种祛痘中药制剂 | |
CN107115476A (zh) | 一种女性护理液 | |
WO2018082117A1 (zh) | 具有祛除皮肤红血丝功能的外用中药组合物及其护肤制剂 | |
CN114601879A (zh) | 一种丰胸乳膏及其制备方法和使用方法 | |
CN105078823A (zh) | 一种减肥组合物及其制备方法 | |
CN115227622A (zh) | 一种防脱养发精华液制作工艺 | |
CN108553530A (zh) | 一种乳腺疏通保养精油及其制作方法 | |
CN108578286A (zh) | 一种臀部塑形精油及其制作方法 | |
CN104095797B (zh) | 一种祛斑的艾纳香组合物及其应用 | |
CN113476387A (zh) | 一种含有中药有效成分的滋养乌发防脱发止痒的洗发水及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220610 |